These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22917269)

  • 61. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Association Between Fecal Calprotectin Levels and Small-bowel Inflammation Score in Capsule Endoscopy: A Multicenter Retrospective Study.
    Koulaouzidis A; Sipponen T; Nemeth A; Makins R; Kopylov U; Nadler M; Giannakou A; Yung DE; Johansson GW; Bartzis L; Thorlacius H; Seidman EG; Eliakim R; Plevris JN; Toth E
    Dig Dis Sci; 2016 Jul; 61(7):2033-40. PubMed ID: 27007135
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Infant Colic Represents Gut Inflammation and Dysbiosis.
    Rhoads JM; Collins J; Fatheree NY; Hashmi SS; Taylor CM; Luo M; Hoang TK; Gleason WA; Van Arsdall MR; Navarro F; Liu Y
    J Pediatr; 2018 Dec; 203():55-61.e3. PubMed ID: 30177353
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.
    Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Leach S; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Jakobovits SL; Florin TH; Gibson PR; Debinski H; Macrae FA; Samuel D; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Day AS; Desmond PV; Gearry RB
    Gastroenterology; 2015 May; 148(5):938-947.e1. PubMed ID: 25620670
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Within-Stool and Within-Day Sample Variability of Fecal Calprotectin in Patients With Inflammatory Bowel Disease: A Prospective Observational Study.
    Du L; Foshaug R; Huang VW; Kroeker KI; Dieleman LA; Halloran BP; Wong K; Fedorak RN
    J Clin Gastroenterol; 2018 Mar; 52(3):235-240. PubMed ID: 28009684
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Faecal calprotectin levels during the first year of life in healthy children.
    Günaydın Şahin BS; Keskindemirci G; Özden TA; Durmaz Ö; Gökçay G
    J Paediatr Child Health; 2020 Nov; 56(11):1806-1811. PubMed ID: 32502317
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Improving the Preoperative Diagnostic Accuracy of Acute Appendicitis. Can Fecal Calprotectin Be Helpful?
    Ambe PC; Orth V; Gödde D; Zirngibl H
    PLoS One; 2016; 11(12):e0168769. PubMed ID: 28033410
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fecal Calprotectin, Elastase, and Alpha-1-Antitrypsin Levels After Roux-en-Y Gastric Bypass; Calprotectin Is Significantly Elevated in the Majority of Patients.
    Boerlage TC; Westerink F; Poland DC; Huibregtse IL; Acherman YI; Gerdes VE
    Obes Surg; 2016 Dec; 26(12):2974-2980. PubMed ID: 27216731
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
    World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease.
    Beltrán B; Iborra M; Sáez-González E; Marqués-Miñana MR; Moret I; Cerrillo E; Tortosa L; Bastida G; Hinojosa J; Poveda-Andrés JL; Nos P
    Dig Dis; 2019; 37(2):108-115. PubMed ID: 30149385
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children.
    Chen CC; Huang JL; Chang CJ; Kong MS
    J Pediatr Gastroenterol Nutr; 2012 Nov; 55(5):541-7. PubMed ID: 22699836
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lactobacillus GG improves recovery in infants with blood in the stools and presumptive allergic colitis compared with extensively hydrolyzed formula alone.
    Baldassarre ME; Laforgia N; Fanelli M; Laneve A; Grosso R; Lifschitz C
    J Pediatr; 2010 Mar; 156(3):397-401. PubMed ID: 19880141
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Agreement Between Home-Based Measurement of Stool Calprotectin and ELISA Results for Monitoring Inflammatory Bowel Disease Activity.
    Heida A; Knol M; Kobold AM; Bootsman J; Dijkstra G; van Rheenen PF
    Clin Gastroenterol Hepatol; 2017 Nov; 15(11):1742-1749.e2. PubMed ID: 28606846
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Point-of-Care Fecal Calprotectin Monitoring in Preterm Infants at Risk for Necrotizing Enterocolitis.
    Nakayuenyongsuk W; Christofferson M; Stevenson DK; Sylvester K; Lee HC; Park KT
    J Pediatr; 2018 May; 196():98-103.e1. PubMed ID: 29519542
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fecal calprotectin for the prediction of small-bowel Crohn's disease by capsule endoscopy: a systematic review and meta-analysis.
    Kopylov U; Yung DE; Engel T; Avni T; Battat R; Ben-Horin S; Plevris JN; Eliakim R; Koulaouzidis A
    Eur J Gastroenterol Hepatol; 2016 Oct; 28(10):1137-44. PubMed ID: 27415156
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Fecal calprotectin levels in preterm infants with and without feeding intolerance.
    Moussa R; Khashana A; Kamel N; Elsharqawy SE
    J Pediatr (Rio J); 2016; 92(5):486-92. PubMed ID: 27317868
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fecal Calprotectin to Detect Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis.
    Ferrara G; Pastore S; Sancin L; Torelli L; Radillo O; Bramuzzo M; Bibalo C; Tommasini A; Ventura A; Taddio A
    J Rheumatol; 2018 Oct; 45(10):1418-1421. PubMed ID: 29907671
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Elevated fecal calprotectin and lactoferrin associated with small intestinal lesions in patients with Behçet disease.
    Hayashida M; Miyoshi J; Mitsui T; Miura M; Saito D; Sakuraba A; Kawashima S; Ikegaya N; Fukuoka K; Karube M; Komagata Y; Kaname S; Okada AA; Fujimori S; Matsuura M; Hisamatsu T
    J Gastroenterol Hepatol; 2020 Aug; 35(8):1340-1346. PubMed ID: 31999379
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's disease.
    Shaoul R; Sladek M; Turner D; Paeregaard A; Veres G; Wauters GV; Escher J; Dias JA; Lionetti P; Staino A; Kolho KL; de Ridder L; Nuti F; Cucchiara S; Sheva O; Levine A;
    Inflamm Bowel Dis; 2012 Aug; 18(8):1493-7. PubMed ID: 22275268
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission?
    Molander P; Färkkilä M; Ristimäki A; Salminen K; Kemppainen H; Blomster T; Koskela R; Jussila A; Rautiainen H; Nissinen M; Haapamäki J; Arkkila P; Nieminen U; Kuisma J; Punkkinen J; Kolho KL; Mustonen H; Sipponen T
    J Crohns Colitis; 2015 Jan; 9(1):33-40. PubMed ID: 25052347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.